Skip to main content
Diasorin logo

Diasorin — Investor Relations & Filings

Ticker · DIA ISIN · IT0003492391 LEI · 8156002878BDF0EE4348 XMIL Manufacturing
Open in API
Filings indexed 817 across all filing types
Latest filing 2023-11-17 Director's Dealing
Country IT Italy
Listing XMIL DIA

About Diasorin

https://diasoringroup.com/en

Diasorin is a global leader in the In Vitro Diagnostic (IVD) field, developing, producing, and marketing reagent kits for laboratory diagnostics. The company specializes in immunodiagnostics and molecular diagnostics. Its immunodiagnostics technology is based on detecting antibodies and antigens in fluid samples to identify diseases or measure physiological markers. The molecular diagnostics division provides flexible tools using targeted and multiplex technologies to detect pathogens in biological specimens. Since 2021, Diasorin has also been active in the Life Science business, offering platforms for biomedical research, clinical diagnostics, and drug discovery. Through its product lines, such as the LIAISON® family of analyzers and assays, the company aims to empower healthcare providers with actionable information to improve patient care, enable faster triage, and reduce unnecessary antibiotic use.

Recent filings

Filing Released Lang Actions
Comunicato Internal Dealing
Director's Dealing Classification · 99% confidence The document is a regulatory filing from DIASORIN, dated November 17, 2023. The key field 'Oggetto' (Subject) explicitly states 'Comunicato Internal Dealing' (Internal Dealing Announcement). Furthermore, the template used is titled 'Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them,' which details the position of an executive ('Amministratore Delegato' - CEO) and their transaction details. This directly corresponds to the definition of Director's Dealing (insider trades by executives).
2023-11-17 Italian
Diasorin 9M 2023 Results Presentation
Investor Presentation Classification · 99% confidence The document is titled "9M 2023 RESULTS" and contains detailed financial highlights for the first nine months of 2023 (9M'23), including Revenues, Adjusted EBITDA, Adjusted EBIT, and Net Profit comparisons. It also includes a section on "MANAGERIAL OUTLOOK ON Q3 AND 9M 2023 REVENUES" and discusses product development and business highlights. This structure—presenting period-specific financial performance data, management commentary, and forward-looking statements within a presentation format—is characteristic of an Investor Presentation (IP) or a document accompanying an Earnings Release (ER). Since it contains detailed financial tables and business updates, it goes beyond a simple Earnings Release (ER) which usually provides only key highlights. The document explicitly mentions the "Diasorin Investor Day 2023" where the Industrial Plan will be presented, further supporting the classification as an Investor Presentation.
2023-11-03 English
Diasorin: i risultati del 3° trimestre confermano la guidance per l’esercizio 2023
Earnings Release Classification · 98% confidence The document text is an official announcement from Diasorin dated November 3, 2023, detailing the 'risultati del 3° trimestre' (3rd quarter results) and confirming the guidance for the 2023 fiscal year. It contains key financial metrics (Revenues, EBITDA, EBIT) for the first 9 months and the 3rd quarter, presented in a structured format typical of an earnings announcement. The subject line explicitly mentions 'i risultati del 3° trimestre' and the content provides summarized financial highlights rather than the full, comprehensive report (which would typically be a 10-Q or a full Annual Report if it were year-end). This structure strongly aligns with an Earnings Release (ER), which provides the initial announcement of periodical financial results (key highlights). It is not a full transcript (CT), a full annual report (10-K), or a comprehensive interim report (IR), as it focuses on the immediate release of results and guidance confirmation. Q3 2023
2023-11-03 Italian
Diasorin: Third Quarter results confirm guidance for Fiscal Year 2023
Earnings Release Classification · 100% confidence The document is a press release from Diasorin S.p.A. detailing their third-quarter and nine-month financial results for 2023. It includes key financial highlights, revenue breakdowns by business line and geography, and management commentary on performance. While it contains financial data, it is structured as an initial announcement of results (a press release) rather than a full statutory interim report. According to the classification rules, this fits the definition of an Earnings Release (ER). 9M 2023
2023-11-03 English
Communication on total amount of voting rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "COMMUNICATION ON TOTAL AMOUNT OF VOTING RIGHTS pursuant to Article 85-bis, paragraph 4-bis, of Consob Regulation no. 11971/1999". It details changes in the total number of voting rights due to the assignment of increased voting rights to a shareholder. This directly relates to shareholder voting structure and rights, which falls under the scope of voting rights announcements. The closest specific category is 'Declaration of Voting Results & Voting Rights Announcements' (DVA), as it explicitly communicates the current status of voting rights following a specific event (assignment of increased rights). It is not a general AGM presentation (AGM-R), nor is it a proxy solicitation (PSI) or a director's dealing report (DIRS).
2023-10-06 English
Comunicazione ammontare complessivo dei diritti di voto
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official communication from DiaSorin S.p.A. titled "COMUNICAZIONE DELL'AMMONTARE COMPLESSIVO DEI DIRITTI DI VOTO ai sensi dell'art. 85-bis, comma 4-bis, del Regolamento Consob n. 11971/1999". This explicitly details changes in the total number of voting rights following a shareholder's acquisition of enhanced voting rights (maggiorazione del diritto di voto). This type of announcement, which reports the results of a shareholder vote or the resulting voting structure, aligns directly with the definition of 'Declaration of Voting Results & Voting Rights Announcements'. The document is short and serves as a regulatory disclosure, not a comprehensive report like a 10-K or IR.
2023-10-06 Italian

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.